Lifting Clinical Trials and Registries Capacity – Clinical Trials Networks
The Australian Government is investing in Clinical Trial Networks to identify important research questions and test the effectiveness of existing and new clinical care.
What we’re funding
The Australian Government has invested $5 million over 4 years in the Australian Clinical Trials Alliance to build the capacity of new and existing Clinical Trials Networks (CTNs).
The purpose of this research funding is to:
- provide better access to and increase recruitment of patients into clinical trials across Australia
- better design the quality and efficiency of clinical trials across Australia
- improve translation of research into clinical practice.
CTNs are collaborative groups of doctors, nurses, and other health and research professionals working together to identify important clinical questions
Funding will provide support for a national alliance partner working with CTNs to improve:
- clinical trial best practice
- knowledge exchange.
Why it’s important
- CTNs are the backbone of the investigator led, clinical trials aimed at improving public health and eradicating disease.
- CTNs lead improved clinical trial productivity, improved outcomes for patients and cost savings to the health system.
- high impact trials conducted by CTNs can provide a return of $5.80 for every research dollar invested.
How to apply
Applications for this program are closed.